IL137684A0 - Salts of paroxetine - Google Patents
Salts of paroxetineInfo
- Publication number
- IL137684A0 IL137684A0 IL13768499A IL13768499A IL137684A0 IL 137684 A0 IL137684 A0 IL 137684A0 IL 13768499 A IL13768499 A IL 13768499A IL 13768499 A IL13768499 A IL 13768499A IL 137684 A0 IL137684 A0 IL 137684A0
- Authority
- IL
- Israel
- Prior art keywords
- paroxetine
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802645.3A GB9802645D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802664.4A GB9802664D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802653.7A GB9802653D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802639.6A GB9802639D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802659.4A GB9802659D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802657.8A GB9802657D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802638.8A GB9802638D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802655.2A GB9802655D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802698.2A GB9802698D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802665.1A GB9802665D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802661.0A GB9802661D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802640.4A GB9802640D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802654.5A GB9802654D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802658.6A GB9802658D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802656.0A GB9802656D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802646.1A GB9802646D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802644.6A GB9802644D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9817309.9A GB9817309D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817364.4A GB9817364D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817307.3A GB9817307D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817360.2A GB9817360D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817344.6A GB9817344D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817321.4A GB9817321D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817359.4A GB9817359D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817340.4A GB9817340D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817317.2A GB9817317D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817320.6A GB9817320D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9817322.2A GB9817322D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9826173.8A GB9826173D0 (en) | 1998-11-30 | 1998-11-30 | Novel compounds |
GBGB9826172.0A GB9826172D0 (en) | 1998-11-30 | 1998-11-30 | Novel compound |
GBGB9827277.6A GB9827277D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
GBGB9827341.0A GB9827341D0 (en) | 1998-12-11 | 1998-12-11 | Novel compounds |
GBGB9828775.8A GB9828775D0 (en) | 1998-12-29 | 1998-12-29 | Novel compounds |
PCT/GB1999/000380 WO1999040084A1 (en) | 1998-02-06 | 1999-02-05 | Salts of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
IL137684A0 true IL137684A0 (en) | 2001-10-31 |
Family
ID=27586915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13768499A IL137684A0 (en) | 1998-02-06 | 1999-02-05 | Salts of paroxetine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1053234A1 (en) |
JP (1) | JP2002505254A (en) |
KR (1) | KR20010040711A (en) |
BG (1) | BG104737A (en) |
CA (1) | CA2319652A1 (en) |
EA (1) | EA200000815A1 (en) |
IL (1) | IL137684A0 (en) |
NO (1) | NO20003960L (en) |
PL (1) | PL342295A1 (en) |
SK (1) | SK11812000A3 (en) |
WO (1) | WO1999040084A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9814316D0 (en) * | 1998-07-02 | 1998-09-02 | Smithkline Beecham Plc | Novel compounds |
CH689805A8 (en) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it. |
EP1102764A1 (en) * | 1998-08-08 | 2001-05-30 | Smithkline Beecham Plc | Paroxetine salts |
GB9827431D0 (en) * | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
WO2000078290A2 (en) * | 1999-06-22 | 2000-12-28 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a salt of paroxetine |
HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
WO2002053561A1 (en) * | 2001-01-05 | 2002-07-11 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
WO2003020717A1 (en) * | 2001-08-02 | 2003-03-13 | Spurcourt Limited | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
KR100672184B1 (en) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Paroxetine cholate or cholic acid derivative salts |
CN108218844B (en) * | 2018-03-08 | 2021-01-19 | 合肥科大生物技术有限公司 | Memantine paroxetine eutectic salt and preparation method, pharmaceutical composition and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
DE3688827T2 (en) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidine derivative, its manufacture and its use as a medicine. |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
-
1999
- 1999-02-05 EA EA200000815A patent/EA200000815A1/en unknown
- 1999-02-05 IL IL13768499A patent/IL137684A0/en unknown
- 1999-02-05 CA CA002319652A patent/CA2319652A1/en not_active Abandoned
- 1999-02-05 JP JP2000530513A patent/JP2002505254A/en active Pending
- 1999-02-05 WO PCT/GB1999/000380 patent/WO1999040084A1/en not_active Application Discontinuation
- 1999-02-05 EP EP99904971A patent/EP1053234A1/en not_active Withdrawn
- 1999-02-05 KR KR1020007008591A patent/KR20010040711A/en not_active Application Discontinuation
- 1999-02-05 SK SK1181-2000A patent/SK11812000A3/en unknown
- 1999-02-05 PL PL99342295A patent/PL342295A1/en not_active Application Discontinuation
-
2000
- 2000-08-04 NO NO20003960A patent/NO20003960L/en not_active Application Discontinuation
- 2000-08-30 BG BG104737A patent/BG104737A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2319652A1 (en) | 1999-08-12 |
SK11812000A3 (en) | 2001-08-06 |
NO20003960D0 (en) | 2000-08-04 |
BG104737A (en) | 2001-07-31 |
NO20003960L (en) | 2000-09-25 |
PL342295A1 (en) | 2001-06-04 |
KR20010040711A (en) | 2001-05-15 |
EA200000815A1 (en) | 2001-02-26 |
EP1053234A1 (en) | 2000-11-22 |
WO1999040084A1 (en) | 1999-08-12 |
JP2002505254A (en) | 2002-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2336364B (en) | Paroxetine salt | |
IL137616A0 (en) | Variants of vegf-a | |
PL346544A1 (en) | Crystalline forms of eto2 | |
IL137684A0 (en) | Salts of paroxetine | |
IL140385A0 (en) | Salts of paroxetine | |
HK1035535A1 (en) | Crystalline forms of osanetant | |
AU1788800A (en) | Derivative of paroxetine | |
IL140766A0 (en) | Novel salts of n-tert-butylhydroxylamine | |
IL138920A0 (en) | Paroxetine maleate | |
IL138478A0 (en) | Paroxetine compositions | |
IL144444A0 (en) | New morpholinobenzamide salts | |
IL139596A0 (en) | Novel formulation containing paroxetine | |
HUP0101215A3 (en) | Chrystalline form of paroxetine | |
IL139081A0 (en) | Paroxetine ascorbate | |
PL344573A1 (en) | Novel formulation containing paroxetine | |
HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
AU1398300A (en) | Amine salts of paroxetine | |
AU5294899A (en) | Paroxetine salts | |
SI1102747T1 (en) | Crystalline forms of osanetant | |
PL340294A1 (en) | Antipsychoic substituted derivatives of piperidine | |
TW392709U (en) | Structure of color-testing machine | |
TW354479U (en) | Improvement of earpick | |
GB9800557D0 (en) | Heterocyclic compounds | |
GB9800567D0 (en) | Heterocyclic compounds | |
GB9800564D0 (en) | Heterocyclic compounds |